90-gene signature assay for tissue origin diagnosis of brain metastases

BACKGROUND: Brain metastases (BM) are the most common intracranial tumors. 2–14% of BM patients present with unknown primary site despite intensive evaluations. This study aims to evaluate the performance of a 90-gene expression signature in determining the primary sites for BM samples. METHODS: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yulong, Ding, Yongfeng, Wang, Qifeng, Sun, Yifeng, Teng, Xiaodong, Gao, Qiqi, Zhong, Weixiang, Lou, Xiaofeng, Xiao, Cheng, Chen, Chengshu, Xu, Qinghua, Xu, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771090/
https://www.ncbi.nlm.nih.gov/pubmed/31570099
http://dx.doi.org/10.1186/s12967-019-2082-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771090/
https://www.ncbi.nlm.nih.gov/pubmed/31570099
http://dx.doi.org/10.1186/s12967-019-2082-1

Ejemplares similares